Skip to main content
. 2019 Apr;11(4):1182–1189. doi: 10.21037/jtd.2019.04.29

Figure 3.

Figure 3

ProGRP distribution in patients with different lung tumors in stage I–II, III and IV. *, P>0.05; **, P<0.05; ***, P<0.001. ProGRP, roles of gastrin-releasing peptide. NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer; LCNEC, large cell neuro-endocrine carcinoma; AC, atypical carcinoid; TC, typical carcinoid; ProGRP, roles of gastrin-releasing peptide.